Results 1 to 10 of about 1,824,517 (243)

Advances in Immunosuppressive Agents Based on Signal Pathway [PDF]

open access: yesFrontiers in Pharmacology, 2022
Immune abnormality involves in various diseases, such as infection, allergic diseases, autoimmune diseases, as well as transplantation. Several signal pathways have been demonstrated to play a central role in the immune response, including JAK/STAT, NF ...
Zhiqing Xu, Zhiqing Xu, Ming Chu
doaj   +4 more sources

Case report: Managing pemphigus foliaceus using apremilast without systemic glucocorticosteroids or immunosuppressive agents [PDF]

open access: yesFrontiers in Immunology
Pemphigus foliaceus (PF) is a superficial form of pemphigus. Treatment options for PF resemble pemphigus vulgaris, including glucocorticosteroids, immunosuppressive agents and rituximab et al.
Quanhong Zhang   +8 more
doaj   +4 more sources

Vaccines: Considerations for pediatric dermatology patients on immunosuppressive agents [PDF]

open access: yesPediatric Dermatology, 2021
Pediatric dermatologists should be aware of immunization schedules and special recommendations for patients on immunosuppressive agents due to the increased risk of vaccine-preventable infections.
Megan H Noe   +2 more
exaly   +3 more sources

New immunosuppressive agents in pediatric transplantation

open access: yesClinics, 2014
Immunosuppressive therapy in pediatrics continues to evolve. Over the past decade, newer immunosuppressive agents have been introduced into adult and pediatric transplant patients with the goal of improving patient and allograft survival.
Christina Nguyen, Ron Shapiro
doaj   +2 more sources

Failure of primary immunosuppressive agents in uveitis [PDF]

open access: yesIndian Journal of Ophthalmology
Purpose: This retrospective study aimed to evaluate the effectiveness of various immunomodulatory therapy (IMT) regimens in managing non-infectious uveitis (NIU) and to identify optimal treatment strategies for refractory cases.
Ankush Kawali   +4 more
doaj   +2 more sources

Efficacy of Tripterygium glycosides in immune-mediated kidney diseases as a immunomodulation drug in combination with conventional immunosuppressive agents: a systematic review and meta-analysis of randomized controlled trials [PDF]

open access: yesFrontiers in Pharmacology
BackgroundImmune-mediated kidney diseases involve the immune system attacking the kidneys, resulting in damage and dysfunction. Tripterygium glycosides (TG) are known for their strong immunosuppressive and anti-inflammatory effects and are commonly used ...
Yaotan Li   +14 more
doaj   +2 more sources

Treatment of uveitis with immunosuppressive agents

open access: yesIndian Journal of Ophthalmology, 1993
The spectrum of uveitis constitutes one of the major causes of blindness. Advances in our understanding of the underlying mechanisms have altered the diagnostic and therapeutic approaches.
Rao Narsing, Buddi Rajeev
doaj   +1 more source

Effect of Immunomodulators and Biologic Agents on Malignancy in Patients with Inflammatory Bowel Disease

open access: yesThe Korean Journal of Gastroenterology, 2017
Immunosuppressive agents and biological agents are widely used for therapy in patients with inflammatory bowel disease (IBD). However, these therapies may be associated with an increased risk of malignancy.
Jee Hyun Kim, Ji Won Kim
doaj   +2 more sources

Acute psychotic disorder associated with immunosuppressive agent use after renal transplantation: a case report

open access: yesPsychiatry and Clinical Psychopharmacology, 2017
Kidney transplantation is the best treatment option for end-stage renal disease in appropriate patients. Immunosuppressant agents given in this duration can cause many psychiatric disorders.
Fulya Gok, Meliha Zengin Eroglu
doaj   +2 more sources

Home - About - Disclaimer - Privacy